Skip to main content

Table 4 Univariate and multivariate analyses of clinical and CT parameters in predicting MVI

From: Prediction of microvascular invasion of hepatocellular carcinoma: value of volumetric iodine quantification using preoperative dual-energy computed tomography

Parameters Univariate analysis Multivariate analysis
Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value
Age (>  60 years) 0.63 (0.16–2.41) 0.50   
Sex (Female) 0.70 (0.16–2.98) 0.63   
Staging of hepatic fibrosis (Stage 4) 1.44 (0.38–5.57) 0.59   
AFP (>  8.7 ng/ml) 2.67 (0.65–10.88) 0.17   
PIVKA-II (>  40 mAU/mL) 4.38 (1.03–18.63) 0.05 2.71 (0.47–15.58) 0.26
Edmondson-Steiner grade of HCC (III) 4.75 (0.95–23.85) 0.06 5.64 (0.67–47.25) 0.11
Total volume of HCC (>  4.5 ml) 2.16 (0.54–8.57) 0.27   
Maximal diameter of HCC (>  32 mm) 4.53 (1.06–19.41) 0.04 4.04 (0.67–24.37) 0.13
Peritumoral enhancement 3.15 (0.78–12.73) 0.11   
Nonsmooth tumor margin 3.00 (0.72–12.55) 0.13   
NIC of outer layer 1 (> 0.082 mg/ml) 6.42 (1.37–30.05) 0.02 7.14 (1.12–45.40) 0.04
  1. Abbreviations: MVI microvascular invasion, AFP Alpha-fetoprotein, PIVKA-II Protein induced by vitamin K absence or antagonist-II, NIC normalized iodine concentration, VOI volume of interest, CI confidence interval